Linked Data API

Show Search Form

Search Results

1760096
registered interest false more like this
date less than 2025-01-29more like thismore than 2025-01-29
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Musculoskeletal Disorders: Preventive Medicine more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government whether they plan to incorporate a role for chiropractors in national musculoskeletal health prevention strategies. more like this
tabling member printed
Baroness Redfern more like this
uin HL4551 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-04more like thismore than 2025-02-04
answer text <p>Improving health outcomes for the over 17 million people in England with musculoskeletal (MSK) conditions forms a key part of the Government's missions to build a National Health Service fit for the future and kickstart economic growth.</p><p>Prevention, early detection, and treatment of these conditions using a multidisciplinary approach can enable people to live in good health and remain independent. As such, the Government recognises the role chiropractic treatment can play in supporting people with MSK-related pain.</p> more like this
answering member printed Baroness Merron more like this
question first answered
less than 2025-02-04T13:48:10.967Zmore like thismore than 2025-02-04T13:48:10.967Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4551
label Biography information for Baroness Redfern more like this
1760099
registered interest false more like this
date less than 2025-01-29more like thismore than 2025-01-29
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Musculoskeletal Disorders: Health Services more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what steps they will take to work with healthcare professionals, including chiropractors, to address workplace-related musculoskeletal issues. more like this
tabling member printed
Baroness Ritchie of Downpatrick more like this
uin HL4554 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-04more like thismore than 2025-02-04
answer text <p>Improving health and work outcomes for the 543,000 workers in Great Britain who reported a work-related musculoskeletal disorder in 2023/24 forms a key part of the Government's missions to build a National Health Service fit for the future and kickstart economic growth.</p><p>Healthcare professionals play a vital prevention and early intervention role in supporting people to self-manage their musculoskeletal condition and enabling them to get in and get on in work.</p><p>The Occupational Health Workforce Expansion Funding Scheme, launched July 2023, funded registered health professionals to undertake occupational health training and qualifications. To date, over 200 doctors and nurses have commenced training.</p><p>The 2025 Healthcare Professionals’ Consensus Statement for action on health and work, published 20 January 2025, commits to work over the next five years to support healthcare professionals, including allied health professionals, to engage more proactively with, and to promote good work as a health outcome across, the health and care sector. This will support patients, including those with musculoskeletal conditions, to return and remain in good work.</p>
answering member printed Baroness Merron more like this
question first answered
less than 2025-02-04T13:47:53.153Zmore like thismore than 2025-02-04T13:47:53.153Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this
1760112
registered interest false more like this
date less than 2025-01-29more like thismore than 2025-01-29
answering body
Cabinet Office more like this
answering dept id 53 more like this
answering dept short name Cabinet Office more like this
answering dept sort name Cabinet Office more like this
hansard heading Government Departments: Cybersecurity more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what steps they are taking to encourage more cyber experts to work in government departments. more like this
tabling member printed
Lord Taylor of Warwick more like this
uin HL4567 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-07more like thismore than 2025-02-07
answer text <p>The Government has been delivering successful cyber programmes for many years.</p><p> </p><p>We bring new talent into His Majesty’s government with our apprenticeship and graduate schemes and a new Government Cyber Skills Academy.</p><p> </p><p>We attract cyber experts into Government with our new Cyber Resourcing Hub which is working to engage with talent pools and support recruiting line managers. The Civil Service Pay Remit Guidance also gives flexibility for departments to offer higher pay for hard-to-recruit-to roles.</p><p> </p> more like this
answering member printed Baroness Twycross more like this
question first answered
less than 2025-02-07T14:56:10.093Zmore like thismore than 2025-02-07T14:56:10.093Z
answering member
4966
label Biography information for Baroness Twycross more like this
tabling member
1796
label Biography information for Lord Taylor of Warwick more like this
1760113
registered interest false more like this
date less than 2025-01-29more like thismore than 2025-01-29
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Cerliponase Alfa more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government when a decision will be taken on authorising and funding the use of Brineura permanently; and what steps they are taking to ensure that the decision is not delayed further. more like this
tabling member printed
Lord Weir of Ballyholme more like this
uin HL4568 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-05more like thismore than 2025-02-05
answer text <p>The National Institute of Health and Care Excellence (NICE) published guidance in 2019 that recommended cerliponase alfa, brand name Brineura, for treating neuronal ceroid lipofuscinosis type 2, within a managed access agreement. This was due to the uncertainty in the evidence base, particularly around the long-term clinical benefits and assumptions about disease stabilisation.</p><p>During this period of managed access, cerliponase alfa has been available to eligible patients while further data was collected to address the clinical uncertainties. The NICE is now carrying out a new evaluation of cerliponase alfa to determine whether it can be recommended for routine National Health Service funding, taking account of the real-world evidence collected during the managed access period. If this evaluation shows that the treatment is a clinically effective and cost-effective use of NHS resources, it will be recommended for routine use in the NHS. All parties are working together to ensure a conclusion to the ongoing evaluation as swiftly as possible.</p>
answering member printed Baroness Merron more like this
grouped question UIN HL4569 more like this
question first answered
less than 2025-02-05T11:45:05.963Zmore like thismore than 2025-02-05T11:45:05.963Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4970
label Biography information for Lord Weir of Ballyholme more like this
1760114
registered interest false more like this
date less than 2025-01-29more like thismore than 2025-01-29
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Batten Disease: Medical Treatments more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government whether permanent funding will remain in place for the treatment of infantile and juvenile Batten disease. more like this
tabling member printed
Lord Weir of Ballyholme more like this
uin HL4569 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-05more like thismore than 2025-02-05
answer text <p>The National Institute of Health and Care Excellence (NICE) published guidance in 2019 that recommended cerliponase alfa, brand name Brineura, for treating neuronal ceroid lipofuscinosis type 2, within a managed access agreement. This was due to the uncertainty in the evidence base, particularly around the long-term clinical benefits and assumptions about disease stabilisation.</p><p>During this period of managed access, cerliponase alfa has been available to eligible patients while further data was collected to address the clinical uncertainties. The NICE is now carrying out a new evaluation of cerliponase alfa to determine whether it can be recommended for routine National Health Service funding, taking account of the real-world evidence collected during the managed access period. If this evaluation shows that the treatment is a clinically effective and cost-effective use of NHS resources, it will be recommended for routine use in the NHS. All parties are working together to ensure a conclusion to the ongoing evaluation as swiftly as possible.</p>
answering member printed Baroness Merron more like this
grouped question UIN HL4568 more like this
question first answered
less than 2025-02-05T11:45:05.917Zmore like thismore than 2025-02-05T11:45:05.917Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4970
label Biography information for Lord Weir of Ballyholme more like this
1759527
registered interest false more like this
date less than 2025-01-28more like thismore than 2025-01-28
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading General Practitioners: Standards more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what proportion of GP practices in the top 20 percent of achievement scores in the Quality and Outcomes Framework had an exception reporting rate above the national average in the most recent financial year for which data are available. more like this
tabling member printed
Lord Agnew of Oulton more like this
uin HL4473 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-04more like thismore than 2025-02-04
answer text <p>Personalised care adjustments (PCAs) replaced exception reporting in 2019. PCAs operate in the same way as exceptions, but PCA specification follows a consistent hierarchy which supports better attribution of the reason for care being personalised.</p><p>The national PCA rate in 2023/24 was 8.2%. 1,253 general practices’ Quality and Outcomes Framework (QOF) achievement rates fell in the top 20% of achievement rates, and of these, 418, or 33.6%, had PCA rates greater than 8.2%. This information is taken from the published QOF statistics, and is available in an online only format on the NHS.UK website.</p> more like this
answering member printed Baroness Merron more like this
question first answered
less than 2025-02-04T13:50:11.937Zmore like thismore than 2025-02-04T13:50:11.937Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4689
label Biography information for Lord Agnew of Oulton more like this
1759532
registered interest false more like this
date less than 2025-01-28more like thismore than 2025-01-28
answering body
Foreign, Commonwealth and Development Office more like this
answering dept id 208 more like this
answering dept short name Foreign, Commonwealth and Development Office more like this
answering dept sort name Foreign, Commonwealth and Development Office more like this
hansard heading Sudan: Hospitals more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what response they have made to the attack on Saudi Teaching Maternal Hospital in Al Fasher, North Darfur State, in Sudan on 24 January, and what part they are playing in bringing those responsible to justice. more like this
tabling member printed
Lord Alton of Liverpool more like this
uin HL4478 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-04more like thismore than 2025-02-04
answer text <p>The UK condemns the attack on the Saudi Hospital in El Fasher in the strongest terms. I have publicly denounced the attack, calling for the protection of civilians and for those responsible for crimes in Darfur to be held to account. The UK Special Representative to Sudan, Richard Crowder, has also condemned the attack alongside Saudi Arabia's Ministry of Foreign Affairs. The UK strongly supports the International Criminal Court's active investigation into the situation in Darfur. This support has included the secondment of expert investigators to support the International Criminal Court's work in a number of countries, including Sudan.</p> more like this
answering member printed Lord Collins of Highbury more like this
question first answered
less than 2025-02-04T17:10:41.317Zmore like thismore than 2025-02-04T17:10:41.317Z
answering member
4222
label Biography information for Lord Collins of Highbury more like this
tabling member
738
label Biography information for Lord Alton of Liverpool more like this
1759538
registered interest false more like this
date less than 2025-01-28more like thismore than 2025-01-28
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Antimicrobials: Drug Resistance more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government, further to the Written Answer by Baroness Merron on 13 January (HC3975) what assessment they have made of the level of compliance with the recommendation in the Joint Royal College of Surgeons of England and Medicines and Healthcare products Regulatory Agency 'Statement on use of topical chlorhexidine for skin preparation prior to surgery'; including any preference for licensed medicinal products over unregulated biocidal forms to prevent antimicrobial resistance and ensure patient safety. more like this
tabling member printed
Baroness Bennett of Manor Castle more like this
uin HL4484 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-04more like thismore than 2025-02-04
answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA), as the regulator for medicines and medical devices in the United Kingdom, continues to recommend the use of licensed medicines. Use of an appropriately authorised product, in accordance with the manufacturer’s instructions for use, ensures the benefit-risk balance remains favourable within its specified indication for use. Assessments and compliance on the use of chlorhexidine is not reported to the MHRA. Adverse reactions to chlorhexidine can be reported to the MHRA through the Yellow Card reporting system by patients and healthcare professionals.</p> more like this
answering member printed Baroness Merron more like this
question first answered
less than 2025-02-04T12:08:27.357Zmore like thismore than 2025-02-04T12:08:27.357Z
answering member
347
label Biography information for Baroness Merron more like this
tabling member
4719
label Biography information for Baroness Bennett of Manor Castle more like this
1759558
registered interest false more like this
date less than 2025-01-28more like thismore than 2025-01-28
answering body
Department for Environment, Food and Rural Affairs more like this
answering dept id 13 more like this
answering dept short name Environment, Food and Rural Affairs more like this
answering dept sort name Environment, Food and Rural Affairs more like this
hansard heading Marine Environment more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of the report from the Office for Environmental Protection, Progress in improving the natural environment in England 2023/2024, published on 16 January, that they may not meet environmental standards for maritime areas. more like this
tabling member printed
Baroness McIntosh of Pickering more like this
uin HL4504 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-05more like thismore than 2025-02-05
answer text <p>My department welcomes the Office for Environmental Protection’s report reviewing “Progress in improving the natural environment in England 2023/2024”. We will respond in full to this report in due course.</p> more like this
answering member printed Baroness Hayman of Ullock more like this
question first answered
less than 2025-02-05T13:40:02.98Zmore like thismore than 2025-02-05T13:40:02.98Z
answering member
4395
label Biography information for Baroness Hayman of Ullock more like this
tabling member
384
label Biography information for Baroness McIntosh of Pickering more like this
1759560
registered interest false more like this
date less than 2025-01-28more like thismore than 2025-01-28
answering body
Treasury more like this
answering dept id 14 more like this
answering dept short name Treasury more like this
answering dept sort name Treasury more like this
hansard heading Pharmacy: Northern Ireland more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what plans they have to provide mitigation to community pharmacies in Northern Ireland before the increase in employers’ National Insurance contributions comes into effect in April. more like this
tabling member printed
Lord Rogan more like this
uin HL4506 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2025-02-05more like thismore than 2025-02-05
answer text <p>At Autumn Budget 2024, the Government provided funding to the public sector to support them with the additional cost associated with changes to Employer National Insurance Contributions.</p><p> </p><p>The Northern Ireland Executive will receive funding through the Barnett formula for any changes to UK Government budgets, including this additional support, in the usual way in 2025-26. This is the normal operation of the funding arrangements as set out in the Statement of Funding Policy.</p><p> </p><p>This funding will be in addition to the Northern Ireland Executive’s record Spending Review settlements for 2025-26, which are the largest in real terms of any settlements since devolution.</p><p> </p><p>Barnett-based funding for the Northern Ireland Executive is not ringfenced for a specific policy area. This allows the Northern Ireland Executive the flexibility to allocate its funding across devolved areas according to its own priorities and local circumstances, including community pharmacies in Northern Ireland.</p>
answering member printed Lord Livermore more like this
question first answered
less than 2025-02-05T11:47:27.983Zmore like thismore than 2025-02-05T11:47:27.983Z
answering member
4559
label Biography information for Lord Livermore more like this
tabling member
2478
label Biography information for Lord Rogan more like this